0001479290-18-000058.txt : 20180323
0001479290-18-000058.hdr.sgml : 20180323
20180323211225
ACCESSION NUMBER: 0001479290-18-000058
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180322
FILED AS OF DATE: 20180323
DATE AS OF CHANGE: 20180323
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SILVERNAIL LAUREN P
CENTRAL INDEX KEY: 0001225755
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36297
FILM NUMBER: 18711478
MAIL ADDRESS:
STREET 1: 15279 ALTON PARKWAY
STREET 2: SUITE #100
CITY: IRVINE
STATE: CA
ZIP: 92618
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Revance Therapeutics, Inc.
CENTRAL INDEX KEY: 0001479290
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 770551645
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 7555 GATEWAY BLVD.
CITY: NEWARK
STATE: CA
ZIP: 94560
BUSINESS PHONE: 510-742-3400
MAIL ADDRESS:
STREET 1: 7555 GATEWAY BLVD.
CITY: NEWARK
STATE: CA
ZIP: 94560
4
1
wf-form4_152185393085906.xml
FORM 4
X0306
4
2018-03-22
0
0001479290
Revance Therapeutics, Inc.
RVNC
0001225755
SILVERNAIL LAUREN P
C/O REVANCE THERAPEUTICS, INC.
7555 GATEWAY BOULEVARD
NEWARK
CA
94560
0
1
0
0
CFO, CBO & Secretary
Common Stock
2018-03-22
4
S
0
3431
30.8478
D
68371
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by Mrs. Silvernail.
The price reported in Table 1, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.6501 to $31.125. Mrs. Silvernail undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
/s/ Gordon Ho, Attorney-in-Fact
2018-03-23